128 related articles for article (PubMed ID: 38662619)
1. Somatostatin vs. Octreotide for Prevention of Postoperative Pancreatic Fistula The PREFIPS Randomized Clinical Trial A FRENCH 007 - ACHBT Study.
Gaujoux S; Regimbeau JM; Piessen G; Truant S; Foissac F; Barbier L; Buc E; Adham M; Fuks D; Deguelte S; Muscari F; Sulpice L; Vaillant JC; Schwarz L; Sa Cunha A; Muzzolini M; Dousset B; Sauvanet A
Ann Surg; 2024 Apr; ():. PubMed ID: 38662619
[TBL] [Abstract][Full Text] [Related]
2. Study Protocol of the PreFiPS Study: Prevention of Postoperative Pancreatic Fistula by Somatostatin Compared With Octreotide, a Prospective Randomized Controlled Trial.
Hain E; Challine A; Tzedakis S; Mare A; Martinino A; Fuks D; Adham M; Piessen G; Regimbeau JM; Buc E; Barbier L; Vaillant JC; Jeune F; Sulpice L; Muscari F; Schwarz L; Deguelte S; Sa Cunha A; Truant S; Dousset B; Sauvanet A; Gaujoux S
Front Med (Lausanne); 2020; 7():488. PubMed ID: 33521003
[No Abstract] [Full Text] [Related]
3. Do somatostatin-analogues have the same impact on postoperative morbidity and pancreatic fistula in patients after pancreaticoduodenectomy and distal pancreatectomy? - A systematic review with meta-analysis of randomized-controlled trials.
Schorn S; Vogel T; Demir IE; Demir E; Safak O; Friess H; Ceyhan GO
Pancreatology; 2020 Dec; 20(8):1770-1778. PubMed ID: 33121847
[TBL] [Abstract][Full Text] [Related]
4. Octreotide and postoperative pancreatic fistula after pancreaticoduodenectomy: What we know so far? A narrative review.
Tilak M; Tewari M; Shukla HS
Indian J Cancer; 2023; 60(2):152-159. PubMed ID: 37530235
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic abdominal drainage or no drainage after distal pancreatectomy (PANDORINA): a binational multicenter randomized controlled trial.
Vissers FL; Balduzzi A; van Bodegraven EA; van Hilst J; Festen S; Hilal MA; Asbun HJ; Mieog JSD; Koerkamp BG; Busch OR; Daams F; Luyer M; De Pastena M; Malleo G; Marchegiani G; Klaase J; Molenaar IQ; Salvia R; van Santvoort HC; Stommel M; Lips D; Coolsen M; Bassi C; van Eijck C; Besselink MG;
Trials; 2022 Sep; 23(1):809. PubMed ID: 36153559
[TBL] [Abstract][Full Text] [Related]
6. The Role of Prophylactic Octreotide Following Pancreaticoduodenectomy to Prevent Postoperative Pancreatic Fistula: A Meta-Analysis of the Randomized Controlled Trials.
Garg PK; Sharma J; Jakhetiya A; Chishi N
Surg J (N Y); 2018 Oct; 4(4):e182-e187. PubMed ID: 30474064
[No Abstract] [Full Text] [Related]
7. Somatostatin analogues for the prevention of pancreatic fistula after open pancreatoduodenectomy: A nationwide analysis.
Bootsma BT; Plat VD; van de Brug T; Huisman DE; Botti M; van den Boezem PB; Bonsing BA; Bosscha K; Dejong CHC; Groot-Koerkamp B; Hagendoorn J; van der Harst E; de Hingh IH; de Meijer VE; Luyer MD; Nieuwenhuijs VB; Pranger BK; van Santvoort HC; Wijsman JH; Zonderhuis BM; Kazemier G; Besselink MG; Daams F;
Pancreatology; 2022 Apr; 22(3):421-426. PubMed ID: 35304104
[TBL] [Abstract][Full Text] [Related]
8. Pancreaticojejunostomy With Externalized Stent vs Pancreaticogastrostomy With Externalized Stent for Patients With High-Risk Pancreatic Anastomosis: A Single-Center, Phase 3, Randomized Clinical Trial.
Andrianello S; Marchegiani G; Malleo G; Masini G; Balduzzi A; Paiella S; Esposito A; Landoni L; Casetti L; Tuveri M; Salvia R; Bassi C
JAMA Surg; 2020 Apr; 155(4):313-321. PubMed ID: 32101272
[TBL] [Abstract][Full Text] [Related]
9. Octreotide prophylaxis is not beneficial for biochemical activity and clinical severity of postoperative pancreatic fistula after pancreatic surgery.
Droeser RA; Jeanmonod P; Schuld J; Moussavian MR; Schilling MK; Kollmar O
Dig Surg; 2012; 29(6):484-91. PubMed ID: 23392293
[TBL] [Abstract][Full Text] [Related]
10. Perioperative hydrocortisone treatment reduces postoperative pancreatic fistula rate after open distal pancreatectomy. A randomized placebo-controlled trial.
Antila A; Siiki A; Sand J; Laukkarinen J
Pancreatology; 2019 Jul; 19(5):786-792. PubMed ID: 31153781
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness comparison of prophylactic octreotide and pasireotide for prevention of fistula after pancreatic surgery.
Welsch T; Müssle B; Distler M; Knoth H; Weitz J; Häckl D
Langenbecks Arch Surg; 2016 Nov; 401(7):1027-1035. PubMed ID: 27233242
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for postoperative pancreatic fistula following non-traumatic, pancreatic surgery. Retrospective observational study.
Mostafa A; Habeeb TA; Neri V; Elshahidy TM; A Fiad A
Ann Ital Chir; 2023; 94():435-442. PubMed ID: 38051507
[TBL] [Abstract][Full Text] [Related]
13. [Impact of octreotide on pancreatic fistula after pancreaticoduodenectomy: a prospective study].
Kong R; Hu J; Li L; Wang G; Chen H; Bai X; Wang Y; Wu L; Jiang H; Sun B
Zhonghua Wai Ke Za Zhi; 2016 Jan; 54(1):21-4. PubMed ID: 26792348
[TBL] [Abstract][Full Text] [Related]
14. Selective Perioperative Administration of Pasireotide is More Cost-Effective Than Routine Administration for Pancreatic Fistula Prophylaxis.
Denbo JW; Slack RS; Bruno M; Cloyd JM; Prakash L; Fleming JB; Kim MP; Aloia TA; Vauthey JN; Lee JE; Katz MH
J Gastrointest Surg; 2017 Apr; 21(4):636-646. PubMed ID: 28050766
[TBL] [Abstract][Full Text] [Related]
15. Effect of Polyglycolic Acid Mesh for Prevention of Pancreatic Fistula Following Distal Pancreatectomy: A Randomized Clinical Trial.
Jang JY; Shin YC; Han Y; Park JS; Han HS; Hwang HK; Yoon DS; Kim JK; Yoon YS; Hwang DW; Kang CM; Lee WJ; Heo JS; Kang MJ; Chang YR; Chang J; Jung W; Kim SW
JAMA Surg; 2017 Feb; 152(2):150-155. PubMed ID: 27784046
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of octreotide in the prevention of complications after pancreaticoduodenectomy in patients with soft pancreas and non-dilated pancreatic duct: A prospective randomized trial.
El Nakeeb A; ElGawalby A; A Ali M; Shehta A; Hamed H; El Refea M; Moneer A; Abd El Rafee A
Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):59-63. PubMed ID: 29428106
[TBL] [Abstract][Full Text] [Related]
17. Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomized placebo-controlled trial.
Yeo CJ; Cameron JL; Lillemoe KD; Sauter PK; Coleman J; Sohn TA; Campbell KA; Choti MA
Ann Surg; 2000 Sep; 232(3):419-29. PubMed ID: 10973392
[TBL] [Abstract][Full Text] [Related]
18. Predicting pancreatic fistula after central pancreatectomy using current fistula risk scores for pancreaticoduodenectomy and distal pancreatectomy.
Yang F; Xu Y; Jin C; Windsor JA; Fu D
Pancreatology; 2023 Nov; 23(7):843-851. PubMed ID: 37739874
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of an absorbable fibrin sealant patch (TachoSil) after distal pancreatectomy: a multicenter, randomized, controlled trial.
Montorsi M; Zerbi A; Bassi C; Capussotti L; Coppola R; Sacchi M;
Ann Surg; 2012 Nov; 256(5):853-9; discussion 859-60. PubMed ID: 23095631
[TBL] [Abstract][Full Text] [Related]
20. Randomized, placebo-controlled study of the efficacy of preoperative somatostatin administration in the prevention of postoperative complications following pancreaticoduodenectomy.
Wang W; Tian B; Babu SR; Zhang Y; Yang M
Hepatogastroenterology; 2013 May; 60(123):400-5. PubMed ID: 23178468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
